Cn6 - Cost-Effectiveness Model of Midostaurin (Mido) Versus Standard of Care (Soc) in Patients With Newly Diagnosed Flt3 Mutation-Positive (Flt3+) Acute Myeloid Leukemia (Aml): A French Perspective

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.023
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Cost-Effectiveness Analysis of Midostaurin (MIDO) With Standard Chemotherapy (SOC) for Acute Myeloid Leukemia (AML) in the United Kingdom (UK)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Radius: Midostaurin (Mido) Plus Standard of Care (SOC) After Allogeneic Stem Cell Transplant (alloSCT) in Patients (Pts) With FLT3-Internal Tandem Duplication (ITD)–Mutated Acute Myeloid Leukemia (AML)

Biology of Blood and Marrow Transplantation
TransplantationHematology
2019English

FLT3-TKD Mutation in Childhood Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2003English

FLT3 Inhibitors in the Treatment of Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2011English

Rational for Targeting the Hedgehog Signalling Pathway in Acute Myeloid Leukemia With FLT3 Mutation

Annals of Translational Medicine
Medicine
2016English

Differential Signaling of Flt3 Activating Mutations in Acute Myeloid Leukemia: A Working Model

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2011English

Association Between Increased Mutation Rates in DNMT3Α and FLT3‑ITD and Poor Prognosis of Patients With Acute Myeloid Leukemia

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Novel Mutations in the FLT3 Gene in Adult Patients With Refractory Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Effect of NPM1 and FLT3 Mutations on the Outcomes of Elderly Patients With Acute Myeloid Leukemia Receiving Standard Chemotherapy

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy